29 untreated breast cancer cell lines vs. pool of all 29 cell lines.

ABSTRACT: Expression profiling of 29 untreated breast cancer cell lines using Agilent 4x44K V1 (G4112F) dual color oligonucleotide microarrays The primary study objective was to establish a research resource for comparative transcriptomic analysis of a series of commercially available breast cancer cell lines representative of diverse histopathologic and molecular subtypes, generated on the Agilent oligonucleotide platform. A specific study objective was to perform a comparative transcriptional analysis of three cell lines established from a patient with triple negative metaplastic inflammatory breast cancer developed by Drs. Felding Habermann and Smider at the Scripps Research Institute, San Diego, CA. Cancer Res 2011;71(24 Suppl):Abstract nr PD03-07. Commercial cell lines were cultured in replete

ORGANISM(S): Homo sapiens

SUBMITTER: Heather Cunliffe 

PROVIDER: E-GEOD-51086 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress